Dr. Yung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 1978 - 1981
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1978 - 1979
- University of California (San Diego) Medical CenterResidency, Neurology, 1975 - 1978
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- FL State Medical License 2021 - Present
- NY State Medical License 1978 - Present
- CA State Medical License 1976 - 2026
- TX State Medical License 1981 - 2026
- OK State Medical License 2020 - 2021
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas Start of enrollment: 1997 Jan 01
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 2001 Jan 05
Publications & Presentations
PubMed
- 69 citationsThe landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.Ilon Liu, Li Jiang, Erik R Samuelsson, Sergio Marco Salas, Alexander Beck
Nature Genetics. 2022-12-01 - 15 citationsEGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma.Jie Ding, Xiaolong Li, Sabbir Khan, Chen Zhang, Feng Gao
Neuro-Oncology. 2022-10-03 - 10 citationsHypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.Benjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, Caroline Chung, Howard Colman
Neuro-Oncology. 2022-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: